US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

7.13

-0.0081-0.11%

Pre-market: 7.390.0900+1.23%08:19 EST

Volume:22.78K

Turnover:164.93K

Market Cap:11.53M

PE:-0.25

High:7.76

Open:7.21

Low:7.00

Close:7.14

52wk High:41.80

52wk Low:5.01

Shares:1.62M

Float Shares:1.18M

Volume Ratio:0.80

T/O Rate:1.92%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-28.3870

EPS(LYR):-66.9021

ROE:-651.40%

ROA:-99.47%

PB:-9.49

PE(LYR):-0.11

Loading ...

Overview Company News Filings

Quoin Pharmaceuticals Files Initial Beneficial Ownership Statement for Stonepine Capital Management

Quoin Pharmaceuticals Submits QRX003 for Orphan Drug Designation and Fast Track Review in Japan

Quoin announces submission to Japanese MHLW for ODD for QRX003

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application for QRX003 in Saudi Arabia

ADRs Close Lower; Quoin Pharmaceuticals Ltd. Declines 36%

Top Premarket Decliners

MT Newswires Live

Quoin Pharmaceuticals Approves New Stock Option Agreements

Quoin Pharmaceuticals Unveils New Equity Incentive Plan for Executives and Directors

Quoin Pharmaceuticals Achieves Key Milestone in Rapamycin Delivery

Quoin Pharmaceuticals Achieves Target Rapamycin Loadings in Topical Delivery Technologies

Quoin Pharmaceuticals Ltd reports results for the quarter ended September 30 - Earnings Summary

Quoin Pharmaceuticals reports Q3 EPS ($6.71) vs. ($16.29) last year

Quoin Pharmaceuticals sees cash runway into 2027

Quoin Pharmaceuticals Q3 EPS $(6.71) Misses $(6.50) Estimate

Press Release: Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results

Quoin Pharmaceuticals Ltd expected to post a loss of $4.98 a share - Earnings Preview

Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Analysts Are Bullish on Top Healthcare Stocks: Quoin Pharmaceuticals (QNRX), Fulcrum Therapeutics (FULC)

Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month ‘Whole Body’ Data Update from Ongoing Study

Quoin Pharmaceuticals’ QRX003 Lotion: A Promising Study for Netherton Syndrome

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/QNRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"QNRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","market":"US","secType":"STK","nameCN":"Quoin Pharmaceuticals","latestPrice":7.13189,"timestamp":1770670800000,"preClose":7.14,"halted":0,"volume":22776,"hourTrading":{"tag":"盘前","latestPrice":7.39,"preClose":7.3,"latestTime":"08:19 EST","volume":4,"amount":29.59,"timestamp":1770729597560,"change":0.09,"changeRate":0.012329,"amplitude":0.00137},"delay":0,"changeRate":-0.00113585434173661,"floatShares":1184400,"shares":1616200,"eps":-28.386957,"marketStatus":"Pre-Mkt","change":-0.00811,"latestTime":"02-10 08:51:26 EST","open":7.21,"high":7.7594,"low":7,"amount":164931.2652,"amplitude":0.106359,"askPrice":8.03,"askSize":100,"bidPrice":6.54,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-28.386957,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"adrRate":35,"exchange":"NASDAQ","adjPreClose":7.3,"preHourTrading":{"tag":"盘前","latestPrice":7.39,"preClose":7.3,"latestTime":"08:19 EST","volume":4,"amount":29.59,"timestamp":1770729597560,"change":0.09,"changeRate":0.012329,"amplitude":0.00137},"postHourTrading":{"tag":"盘后","latestPrice":7.13189,"preClose":7.13189,"latestTime":"18:59 EST","volume":35,"amount":258.3,"timestamp":1770681590173,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.802933092589061},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","floatShares":1184400,"roa":"-99.47%","roe":"-651.40%","lyrEps":-66.902093,"volumeRatio":0.802933092589061,"shares":1616200,"dividePrice":0,"high":7.7594,"amplitude":0.106359,"preClose":7.14,"low":7,"week52Low":5.01,"pbRate":"-9.49","week52High":41.8,"institutionHeld":0,"latestPrice":7.13189,"eps":-28.386957,"divideRate":0,"volume":22776,"delay":0,"ttmEps":-28.386957,"open":7.21,"prevYearClose":14.43,"prevWeekClose":7.14,"prevMonthClose":7.215,"prevQuarterClose":14.43,"fiveDayClose":8,"twentyDayClose":12.21,"sixtyDayClose":11.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QNRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"QNRX","fiscalQuarterEnding":"2025/09","expectedEps":-6.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-6.71},{"market":"US","date":"2025-08-07","symbol":"QNRX","fiscalQuarterEnding":"2025/06","expectedEps":-6.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-6.28},{"market":"US","date":"2025-05-13","symbol":"QNRX","fiscalQuarterEnding":"2025/03","expectedEps":-3.85,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-6.5},{"market":"US","date":"2025-04-09","symbol":"QNRX","defaultRemindTime":1744205400000,"type":"split","dateTimestamp":1744171200000,"forFactor":35,"toFactor":1,"ratio":35},{"market":"US","date":"2025-03-13","symbol":"QNRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.35}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QNRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QNRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1718341200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QNRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QNRX","date":"2026-02-09","current":-0.251238,"percent":0.566507,"low":-17.346367,"twenty":-0.735083,"median":-0.476783,"eighty":-0.336018,"high":-0.000007,"avg":-0.765255,"sd":1.552529,"marketCap":5990288},"quantilePoints":[{"date":"2021-10-29","current":-17.346367,"twenty":-17.346367,"median":-17.346367,"eighty":-17.346367,"marketCap":97148313},{"date":"2021-11-05","current":-12.667021,"twenty":-16.958905,"median":-15.73691,"eighty":-14.60433,"marketCap":70941637},{"date":"2021-11-12","current":-8.658281,"twenty":-16.765174,"median":-12.667021,"eighty":-10.28264,"marketCap":48490695},{"date":"2021-11-19","current":-7.615115,"twenty":-14.708646,"median":-10.506176,"eighty":-8.241015,"marketCap":42648443},{"date":"2021-11-26","current":-3.943296,"twenty":-14.625193,"median":-8.598672,"eighty":-7.442247,"marketCap":37807719},{"date":"2021-12-03","current":-2.811666,"twenty":-13.054483,"median":-8.241015,"eighty":-3.931109,"marketCap":26957822},{"date":"2021-12-10","current":-3.055402,"twenty":-11.760956,"median":-7.592761,"eighty":-3.245167,"marketCap":29294723},{"date":"2021-12-17","current":-1.862838,"twenty":-10.890658,"median":-4.02164,"eighty":-3.025805,"marketCap":17860600},{"date":"2021-12-23","current":-1.549649,"twenty":-10.461469,"median":-3.943296,"eighty":-2.794256,"marketCap":16525228},{"date":"2021-12-31","current":-1.424425,"twenty":-9.308025,"median":-3.294786,"eighty":-1.787652,"marketCap":15189856},{"date":"2022-01-07","current":-1.627915,"twenty":-8.58675,"median":-3.203384,"eighty":-1.577825,"marketCap":17359836},{"date":"2022-01-14","current":-1.267895,"twenty":-8.485414,"median":-3.107631,"eighty":-1.488603,"marketCap":13520641},{"date":"2022-01-21","current":-1.0331,"twenty":-8.366195,"median":-2.876952,"eighty":-1.447905,"marketCap":11016819},{"date":"2022-01-28","current":-0.970488,"twenty":-8.163523,"median":-2.768142,"eighty":-1.377466,"marketCap":10349133},{"date":"2022-02-04","current":-1.111365,"twenty":-7.874416,"median":-1.976001,"eighty":-1.235023,"marketCap":11851426},{"date":"2022-02-11","current":-1.085306,"twenty":-7.597232,"median":-1.674874,"eighty":-1.127775,"marketCap":11573542},{"date":"2022-02-18","current":-1.061713,"twenty":-7.314087,"median":-1.573129,"eighty":-1.113525,"marketCap":11321943},{"date":"2022-02-25","current":-0.865099,"twenty":-6.348012,"median":-1.498777,"eighty":-1.105103,"marketCap":9225287},{"date":"2022-03-04","current":-0.904422,"twenty":-4.019899,"median":-1.479211,"eighty":-1.071673,"marketCap":9644618},{"date":"2022-03-11","current":-1.163952,"twenty":-3.999007,"median":-1.447905,"eighty":-1.061713,"marketCap":12412205},{"date":"2022-03-18","current":-1.163952,"twenty":-3.931109,"median":-1.416599,"eighty":-1.037796,"marketCap":12412205},{"date":"2022-03-25","current":-1.148223,"twenty":-3.765718,"median":-1.381379,"eighty":-1.057606,"marketCap":12244472},{"date":"2022-04-01","current":-1.053848,"twenty":-3.297397,"median":-1.299201,"eighty":-1.053848,"marketCap":11238077},{"date":"2022-04-08","current":-0.928015,"twenty":-3.283469,"median":-1.222936,"eighty":-1.035677,"marketCap":9896217},{"date":"2022-04-14","current":-0.476722,"twenty":-3.255613,"median":-1.205283,"eighty":-1.00962,"marketCap":10231682},{"date":"2022-04-22","current":-0.410293,"twenty":-3.203384,"median":-1.163952,"eighty":-0.975203,"marketCap":8805956},{"date":"2022-04-29","current":-0.313073,"twenty":-3.185975,"median":-1.153274,"eighty":-0.954835,"marketCap":6719363},{"date":"2022-05-06","current":-0.308697,"twenty":-3.15986,"median":-1.132494,"eighty":-0.920151,"marketCap":6625433},{"date":"2022-05-13","current":-0.243519,"twenty":-3.055402,"median":-1.120697,"eighty":-0.880828,"marketCap":5226544},{"date":"2022-05-20","current":-0.246137,"twenty":-2.907419,"median":-1.111365,"eighty":-0.857235,"marketCap":5282735},{"date":"2022-05-27","current":-0.275987,"twenty":-2.846486,"median":-1.107451,"eighty":-0.468907,"marketCap":5310410},{"date":"2022-06-03","current":-0.26812,"twenty":-2.81863,"median":-1.087972,"eighty":-0.44468,"marketCap":5159040},{"date":"2022-06-10","current":-0.203983,"twenty":-2.776847,"median":-1.085306,"eighty":-0.385285,"marketCap":3924940},{"date":"2022-06-17","current":-0.152291,"twenty":-2.489587,"median":-1.07351,"eighty":-0.319364,"marketCap":2930308},{"date":"2022-06-24","current":-0.155212,"twenty":-2.221478,"median":-1.061713,"eighty":-0.298542,"marketCap":2986515},{"date":"2022-07-01","current":-0.267305,"twenty":-1.953368,"median":-1.056579,"eighty":-0.277405,"marketCap":5143349},{"date":"2022-07-08","current":-0.231074,"twenty":-1.787652,"median":-1.053848,"eighty":-0.273302,"marketCap":4446216},{"date":"2022-07-15","current":-0.178755,"twenty":-1.674874,"median":-1.039542,"eighty":-0.267462,"marketCap":3439525},{"date":"2022-07-22","current":-0.183115,"twenty":-1.65609,"median":-1.030254,"eighty":-0.25072,"marketCap":3523416},{"date":"2022-07-29","current":-0.155517,"twenty":-1.615393,"median":-0.994864,"eighty":-0.244988,"marketCap":2992387},{"date":"2022-08-05","current":-1.0024,"twenty":-1.577825,"median":-0.983067,"eighty":-0.2438,"marketCap":19287705},{"date":"2022-08-12","current":-0.905761,"twenty":-1.530865,"median":-0.979135,"eighty":-0.244988,"marketCap":17428209},{"date":"2022-08-19","current":-1.261787,"twenty":-1.49956,"median":-0.983067,"eighty":-0.24634,"marketCap":22172308},{"date":"2022-08-26","current":-1.00506,"twenty":-1.494864,"median":-1.00373,"eighty":-0.247189,"marketCap":17661059},{"date":"2022-09-02","current":-0.83846,"twenty":-1.488603,"median":-0.983067,"eighty":-0.248209,"marketCap":14733547},{"date":"2022-09-09","current":-1.015985,"twenty":-1.47295,"median":-0.985942,"eighty":-0.249617,"marketCap":17853027},{"date":"2022-09-16","current":-0.999598,"twenty":-1.447905,"median":-1.000999,"eighty":-0.2541,"marketCap":17565075},{"date":"2022-09-23","current":-0.80537,"twenty":-1.447905,"median":-0.994135,"eighty":-0.255867,"marketCap":14152083},{"date":"2022-09-30","current":-0.61506,"twenty":-1.446166,"median":-0.983139,"eighty":-0.262906,"marketCap":10807926},{"date":"2022-10-07","current":-0.604028,"twenty":-1.436253,"median":-0.98189,"eighty":-0.267383,"marketCap":10614062},{"date":"2022-10-14","current":-0.471638,"twenty":-1.42286,"median":-0.968913,"eighty":-0.267782,"marketCap":8287692},{"date":"2022-10-21","current":-0.562656,"twenty":-1.413468,"median":-0.966397,"eighty":-0.2688,"marketCap":9887072},{"date":"2022-10-28","current":-0.529559,"twenty":-1.393119,"median":-0.950476,"eighty":-0.271699,"marketCap":9305479},{"date":"2022-11-04","current":-0.485429,"twenty":-1.358698,"median":-0.943659,"eighty":-0.272858,"marketCap":8530023},{"date":"2022-11-11","current":-0.479672,"twenty":-1.345188,"median":-0.923004,"eighty":-0.274906,"marketCap":9208547},{"date":"2022-11-18","current":-0.459476,"twenty":-1.332632,"median":-0.91334,"eighty":-0.276144,"marketCap":8820819},{"date":"2022-11-25","current":-0.462,"twenty":-1.299201,"median":-0.906739,"eighty":-0.276772,"marketCap":8869285},{"date":"2022-12-02","current":-0.441804,"twenty":-1.267895,"median":-0.903164,"eighty":-0.277827,"marketCap":8481557},{"date":"2022-12-09","current":-0.393836,"twenty":-1.261787,"median":-0.893083,"eighty":-0.277839,"marketCap":7560702},{"date":"2022-12-16","current":-0.386263,"twenty":-1.226868,"median":-0.869031,"eighty":-0.278907,"marketCap":7415304},{"date":"2022-12-23","current":-0.333246,"twenty":-1.219003,"median":-0.857235,"eighty":-0.28331,"marketCap":6397517},{"date":"2022-12-30","current":-0.358492,"twenty":-1.214288,"median":-0.83846,"eighty":-0.285895,"marketCap":6882177},{"date":"2023-01-06","current":-0.366066,"twenty":-1.203717,"median":-0.830267,"eighty":-0.294872,"marketCap":7027575},{"date":"2023-01-13","current":-0.419082,"twenty":-1.196726,"median":-0.751587,"eighty":-0.305389,"marketCap":8045362},{"date":"2023-01-20","current":-0.388787,"twenty":-1.192762,"median":-0.704699,"eighty":-0.310447,"marketCap":7463770},{"date":"2023-01-27","current":-0.393836,"twenty":-1.178108,"median":-0.684013,"eighty":-0.314277,"marketCap":7560702},{"date":"2023-02-03","current":-0.59078,"twenty":-1.163952,"median":-0.661949,"eighty":-0.317723,"marketCap":11341538},{"date":"2023-02-10","current":-0.421607,"twenty":-1.163758,"median":-0.631609,"eighty":-0.320717,"marketCap":8093828},{"date":"2023-02-17","current":-0.353443,"twenty":-1.161409,"median":-0.60749,"eighty":-0.323804,"marketCap":6785245},{"date":"2023-02-24","current":-0.118656,"twenty":-1.156304,"median":-0.591888,"eighty":-0.313675,"marketCap":2277903},{"date":"2023-03-03","current":-0.281484,"twenty":-1.14665,"median":-0.562656,"eighty":-0.29262,"marketCap":5403806},{"date":"2023-03-10","current":-0.522124,"twenty":-1.138785,"median":-0.550992,"eighty":-0.287367,"marketCap":4898302},{"date":"2023-03-17","current":-0.593625,"twenty":-1.130921,"median":-0.551624,"eighty":-0.29122,"marketCap":5569088},{"date":"2023-03-24","current":-0.65651,"twenty":-1.124629,"median":-0.575443,"eighty":-0.294825,"marketCap":6159049},{"date":"2023-03-31","current":-0.60057,"twenty":-1.123056,"median":-0.592995,"eighty":-0.300426,"marketCap":5634244},{"date":"2023-04-06","current":-0.603601,"twenty":-1.116764,"median":-0.60057,"eighty":-0.300426,"marketCap":5662676},{"date":"2023-04-14","current":-0.560679,"twenty":-1.116764,"median":-0.592742,"eighty":-0.308697,"marketCap":5260010},{"date":"2023-04-21","current":-0.580997,"twenty":-1.111365,"median":-0.593625,"eighty":-0.313073,"marketCap":5450622},{"date":"2023-04-28","current":-0.649313,"twenty":-1.111365,"median":-0.598171,"eighty":-0.316082,"marketCap":6091523},{"date":"2023-05-05","current":-0.60259,"twenty":-1.111365,"median":-0.60259,"eighty":-0.320185,"marketCap":5653199},{"date":"2023-05-12","current":-0.55198,"twenty":-1.103538,"median":-0.60158,"eighty":-0.321514,"marketCap":5686369},{"date":"2023-05-19","current":-0.55198,"twenty":-1.10065,"median":-0.595771,"eighty":-0.327238,"marketCap":5686369},{"date":"2023-05-26","current":-0.505982,"twenty":-1.088059,"median":-0.592742,"eighty":-0.333246,"marketCap":5212505},{"date":"2023-06-02","current":-0.499658,"twenty":-1.08792,"median":-0.589505,"eighty":-0.344867,"marketCap":5147361},{"date":"2023-06-09","current":-0.55704,"twenty":-1.087172,"median":-0.580997,"eighty":-0.350289,"marketCap":5738494},{"date":"2023-06-16","current":-0.620978,"twenty":-1.085644,"median":-0.584704,"eighty":-0.352938,"marketCap":6397166},{"date":"2023-06-23","current":-0.676176,"twenty":-1.085306,"median":-0.589505,"eighty":-0.356472,"marketCap":6965803},{"date":"2023-06-30","current":-0.593264,"twenty":-1.083207,"median":-0.591634,"eighty":-0.359502,"marketCap":6111663},{"date":"2023-07-07","current":-0.517481,"twenty":-1.079536,"median":-0.587708,"eighty":-0.361522,"marketCap":5330971},{"date":"2023-07-14","current":-0.54646,"twenty":-1.077168,"median":-0.582224,"eighty":-0.364046,"marketCap":5629506},{"date":"2023-07-21","current":-0.623853,"twenty":-1.07607,"median":-0.587708,"eighty":-0.366571,"marketCap":6426782},{"date":"2023-07-28","current":-0.721599,"twenty":-1.07607,"median":-0.591634,"eighty":-0.36859,"marketCap":7433744},{"date":"2023-08-04","current":-0.757094,"twenty":-1.073339,"median":-0.593264,"eighty":-0.36859,"marketCap":7374510},{"date":"2023-08-11","current":-0.62027,"twenty":-1.070607,"median":-0.595859,"eighty":-0.371115,"marketCap":6041768},{"date":"2023-08-18","current":-0.543243,"twenty":-1.069577,"median":-0.593625,"eighty":-0.376164,"marketCap":5291483},{"date":"2023-08-25","current":-0.538176,"twenty":-1.067876,"median":-0.592742,"eighty":-0.378689,"marketCap":5242122},{"date":"2023-09-01","current":-0.58277,"twenty":-1.065691,"median":-0.589505,"eighty":-0.378689,"marketCap":5676497},{"date":"2023-09-08","current":-0.590878,"twenty":-1.063086,"median":-0.590829,"eighty":-0.378689,"marketCap":5755475},{"date":"2023-09-15","current":-0.569594,"twenty":-1.061713,"median":-0.58823,"eighty":-0.378689,"marketCap":5548159},{"date":"2023-09-22","current":-0.506757,"twenty":-1.061713,"median":-0.585904,"eighty":-0.378689,"marketCap":4936085},{"date":"2023-09-29","current":-0.433865,"twenty":-1.060727,"median":-0.581611,"eighty":-0.380709,"marketCap":4226078},{"date":"2023-10-06","current":-0.427703,"twenty":-1.05818,"median":-0.578696,"eighty":-0.383738,"marketCap":4166055},{"date":"2023-10-13","current":-0.408953,"twenty":-1.055487,"median":-0.574156,"eighty":-0.383738,"marketCap":3983420},{"date":"2023-10-20","current":-0.41554,"twenty":-1.053848,"median":-0.568243,"eighty":-0.383738,"marketCap":4047589},{"date":"2023-10-27","current":-0.435811,"twenty":-1.053848,"median":-0.56578,"eighty":-0.383738,"marketCap":4245033},{"date":"2023-11-03","current":-0.435811,"twenty":-1.053848,"median":-0.56554,"eighty":-0.384243,"marketCap":4245033},{"date":"2023-11-10","current":-0.411508,"twenty":-1.050251,"median":-0.562656,"eighty":-0.384243,"marketCap":4008308},{"date":"2023-11-17","current":-0.498316,"twenty":-1.046658,"median":-0.560987,"eighty":-0.385884,"marketCap":4304279},{"date":"2023-11-24","current":-0.522671,"twenty":-1.041435,"median":-0.560318,"eighty":-0.386263,"marketCap":4514655},{"date":"2023-12-01","current":-0.568388,"twenty":-1.035221,"median":-0.558953,"eighty":-0.387777,"marketCap":4909543},{"date":"2023-12-08","current":-0.568034,"twenty":-1.0331,"median":-0.560318,"eighty":-0.388787,"marketCap":4906483},{"date":"2023-12-15","current":-0.484601,"twenty":-1.031392,"median":-0.558953,"eighty":-0.389637,"marketCap":4185812},{"date":"2023-12-22","current":-0.477732,"twenty":-1.021693,"median":-0.557743,"eighty":-0.390868,"marketCap":4126480},{"date":"2023-12-29","current":-0.588241,"twenty":-1.014712,"median":-0.55704,"eighty":-0.391312,"marketCap":5081023},{"date":"2024-01-05","current":-0.532603,"twenty":-1.010893,"median":-0.55589,"eighty":-0.391312,"marketCap":4600445},{"date":"2024-01-12","current":-0.526889,"twenty":-1.007253,"median":-0.553378,"eighty":-0.393331,"marketCap":4551084},{"date":"2024-01-19","current":-0.454873,"twenty":-1.0057,"median":-0.55198,"eighty":-0.393836,"marketCap":3929036},{"date":"2024-01-26","current":-0.427454,"twenty":-1.003464,"median":-0.551802,"eighty":-0.393836,"marketCap":3692202},{"date":"2024-02-02","current":-0.394309,"twenty":-1.000719,"median":-0.549335,"eighty":-0.39412,"marketCap":3405909},{"date":"2024-02-09","current":-0.38288,"twenty":-0.99632,"median":-0.548588,"eighty":-0.392826,"marketCap":3307187},{"date":"2024-02-16","current":-0.318876,"twenty":-0.989219,"median":-0.547495,"eighty":-0.388787,"marketCap":2754343},{"date":"2024-02-23","current":-0.301732,"twenty":-0.98485,"median":-0.546977,"eighty":-0.385127,"marketCap":2606260},{"date":"2024-03-01","current":-0.314316,"twenty":-0.983153,"median":-0.545642,"eighty":-0.383738,"marketCap":2714953},{"date":"2024-03-08","current":-0.135997,"twenty":-0.983067,"median":-0.543349,"eighty":-0.379908,"marketCap":1174693},{"date":"2024-03-15","current":-0.20704,"twenty":-0.982596,"median":-0.542611,"eighty":-0.378689,"marketCap":1798470},{"date":"2024-03-22","current":-0.381897,"twenty":-0.979215,"median":-0.541631,"eighty":-0.378689,"marketCap":3317373},{"date":"2024-03-28","current":-0.369167,"twenty":-0.97426,"median":-0.540481,"eighty":-0.37767,"marketCap":3206793},{"date":"2024-04-05","current":-0.364923,"twenty":-0.969858,"median":-0.539696,"eighty":-0.377263,"marketCap":3169934},{"date":"2024-04-12","current":-0.326734,"twenty":-0.967338,"median":-0.538176,"eighty":-0.369557,"marketCap":2838196},{"date":"2024-04-19","current":-0.305517,"twenty":-0.96715,"median":-0.536661,"eighty":-0.365152,"marketCap":2653898},{"date":"2024-04-26","current":-0.267328,"twenty":-0.964085,"median":-0.533552,"eighty":-0.358997,"marketCap":2322161},{"date":"2024-05-03","current":-0.309761,"twenty":-0.95419,"median":-0.531461,"eighty":-0.351423,"marketCap":2690758},{"date":"2024-05-10","current":-0.337342,"twenty":-0.951156,"median":-0.528981,"eighty":-0.340821,"marketCap":2930346},{"date":"2024-05-17","current":-0.367202,"twenty":-0.948223,"median":-0.527946,"eighty":-0.340821,"marketCap":3088456},{"date":"2024-05-24","current":-0.34075,"twenty":-0.943728,"median":-0.525421,"eighty":-0.340947,"marketCap":2865976},{"date":"2024-05-31","current":-0.331712,"twenty":-0.943659,"median":-0.525,"eighty":-0.340592,"marketCap":2789958},{"date":"2024-06-07","current":-0.346334,"twenty":-0.928015,"median":-0.523469,"eighty":-0.340703,"marketCap":2912940},{"date":"2024-06-14","current":-0.340703,"twenty":-0.926289,"median":-0.522398,"eighty":-0.340681,"marketCap":2865578},{"date":"2024-06-21","current":-0.295228,"twenty":-0.922433,"median":-0.519905,"eighty":-0.336816,"marketCap":2483103},{"date":"2024-06-28","current":-0.279187,"twenty":-0.920151,"median":-0.518004,"eighty":-0.336018,"marketCap":2348182},{"date":"2024-07-05","current":-0.274313,"twenty":-0.920151,"median":-0.512285,"eighty":-0.333064,"marketCap":2307188},{"date":"2024-07-12","current":-0.307579,"twenty":-0.914702,"median":-0.509745,"eighty":-0.331195,"marketCap":2586980},{"date":"2024-07-15","current":-0.310418,"twenty":-0.91334,"median":-0.508665,"eighty":-0.331019,"marketCap":2610860},{"date":"2024-08-02","current":-0.272562,"twenty":-0.913129,"median":-0.507585,"eighty":-0.329729,"marketCap":2292462},{"date":"2024-08-09","current":-0.248051,"twenty":-0.911177,"median":-0.505359,"eighty":-0.325114,"marketCap":2086300},{"date":"2024-08-16","current":-0.24035,"twenty":-0.906543,"median":-0.501744,"eighty":-0.319687,"marketCap":1989587},{"date":"2024-08-23","current":-0.293286,"twenty":-0.905493,"median":-0.497744,"eighty":-0.316091,"marketCap":2427781},{"date":"2024-08-30","current":-0.286555,"twenty":-0.903919,"median":-0.49203,"eighty":-0.313322,"marketCap":2372062},{"date":"2024-09-06","current":-0.383339,"twenty":-0.901905,"median":-0.490945,"eighty":-0.313073,"marketCap":3173230},{"date":"2024-09-13","current":-0.311556,"twenty":-0.894391,"median":-0.486542,"eighty":-0.313073,"marketCap":2579020},{"date":"2024-09-20","current":-0.276506,"twenty":-0.893083,"median":-0.485429,"eighty":-0.309761,"marketCap":2288880},{"date":"2024-09-27","current":-0.252418,"twenty":-0.880828,"median":-0.484661,"eighty":-0.307436,"marketCap":2089484},{"date":"2024-10-04","current":-0.23434,"twenty":-0.872964,"median":-0.484601,"eighty":-0.302929,"marketCap":1939837},{"date":"2024-10-11","current":-0.252827,"twenty":-0.865099,"median":-0.482434,"eighty":-0.301027,"marketCap":2092867},{"date":"2024-10-18","current":-0.317326,"twenty":-0.857235,"median":-0.47841,"eighty":-0.300426,"marketCap":2626780},{"date":"2024-10-25","current":-0.39995,"twenty":-0.857235,"median":-0.476537,"eighty":-0.300426,"marketCap":3310734},{"date":"2024-10-31","current":-0.494182,"twenty":-0.850943,"median":-0.478071,"eighty":-0.300907,"marketCap":4090778},{"date":"2024-11-08","current":-0.422626,"twenty":-0.840642,"median":-0.476351,"eighty":-0.301191,"marketCap":3498446},{"date":"2024-11-15","current":-0.352287,"twenty":-0.834605,"median":-0.468894,"eighty":-0.301334,"marketCap":3065275},{"date":"2024-11-22","current":-0.359821,"twenty":-0.830942,"median":-0.464302,"eighty":-0.301657,"marketCap":3130826},{"date":"2024-11-29","current":-0.348213,"twenty":-0.815329,"median":-0.462,"eighty":-0.30245,"marketCap":3029832},{"date":"2024-12-06","current":-0.435267,"twenty":-0.804556,"median":-0.461782,"eighty":-0.30359,"marketCap":3787290},{"date":"2024-12-13","current":-0.420758,"twenty":-0.775862,"median":-0.460599,"eighty":-0.304922,"marketCap":3661047},{"date":"2024-12-20","current":-0.375374,"twenty":-0.755346,"median":-0.458782,"eighty":-0.305517,"marketCap":3266158},{"date":"2024-12-27","current":-0.324419,"twenty":-0.754181,"median":-0.457684,"eighty":-0.304625,"marketCap":2822793},{"date":"2025-01-03","current":-0.389709,"twenty":-0.753938,"median":-0.457139,"eighty":-0.305517,"marketCap":3390886},{"date":"2025-01-10","current":-0.36162,"twenty":-0.752966,"median":-0.455912,"eighty":-0.305517,"marketCap":3146480},{"date":"2025-01-17","current":-0.342177,"twenty":-0.750208,"median":-0.452331,"eighty":-0.307436,"marketCap":2977309},{"date":"2025-01-24","current":-0.238758,"twenty":-0.74342,"median":-0.451013,"eighty":-0.307052,"marketCap":2077454},{"date":"2025-01-31","current":-0.167665,"twenty":-0.737124,"median":-0.449377,"eighty":-0.30269,"marketCap":1458864},{"date":"2025-02-07","current":-0.757086,"twenty":-0.737124,"median":-0.448569,"eighty":-0.301334,"marketCap":6587465},{"date":"2025-02-14","current":-0.783111,"twenty":-0.74342,"median":-0.449855,"eighty":-0.301657,"marketCap":6813909},{"date":"2025-02-21","current":-0.78737,"twenty":-0.751311,"median":-0.451168,"eighty":-0.30245,"marketCap":6850964},{"date":"2025-02-28","current":-0.840366,"twenty":-0.753452,"median":-0.452677,"eighty":-0.30359,"marketCap":7312086},{"date":"2025-03-07","current":-0.710242,"twenty":-0.753452,"median":-0.457022,"eighty":-0.304922,"marketCap":6179866},{"date":"2025-03-14","current":-0.697939,"twenty":-0.751311,"median":-0.45752,"eighty":-0.305517,"marketCap":6072819},{"date":"2025-03-21","current":-0.666099,"twenty":-0.746669,"median":-0.458782,"eighty":-0.306668,"marketCap":5969890},{"date":"2025-03-28","current":-0.654614,"twenty":-0.742758,"median":-0.460599,"eighty":-0.307522,"marketCap":5866961},{"date":"2025-04-04","current":-0.597422,"twenty":-0.741572,"median":-0.462322,"eighty":-0.30825,"marketCap":5354374},{"date":"2025-04-11","current":-0.360284,"twenty":-0.741572,"median":-0.462,"eighty":-0.309143,"marketCap":3229031},{"date":"2025-04-17","current":-0.393753,"twenty":-0.739272,"median":-0.460599,"eighty":-0.309568,"marketCap":3528996},{"date":"2025-04-25","current":-0.435271,"twenty":-0.735618,"median":-0.459466,"eighty":-0.310024,"marketCap":3901103},{"date":"2025-05-02","current":-0.433456,"twenty":-0.734421,"median":-0.458108,"eighty":-0.310681,"marketCap":3884836},{"date":"2025-05-09","current":-0.410992,"twenty":-0.733427,"median":-0.457352,"eighty":-0.311268,"marketCap":3683507},{"date":"2025-05-16","current":-0.433495,"twenty":-0.733238,"median":-0.456951,"eighty":-0.312163,"marketCap":4528878},{"date":"2025-05-23","current":-0.476844,"twenty":-0.73159,"median":-0.457022,"eighty":-0.313182,"marketCap":4981766},{"date":"2025-05-30","current":-0.510623,"twenty":-0.72928,"median":-0.457352,"eighty":-0.313539,"marketCap":5334665},{"date":"2025-06-06","current":-0.492889,"twenty":-0.726897,"median":-0.458108,"eighty":-0.314338,"marketCap":5149393},{"date":"2025-06-13","current":-0.476844,"twenty":-0.721599,"median":-0.460002,"eighty":-0.314632,"marketCap":4981766},{"date":"2025-06-20","current":-0.472762,"twenty":-0.721599,"median":-0.461082,"eighty":-0.315448,"marketCap":4939123},{"date":"2025-06-27","current":-0.547779,"twenty":-0.720641,"median":-0.462644,"eighty":-0.316082,"marketCap":5722855},{"date":"2025-07-03","current":-0.495422,"twenty":-0.717621,"median":-0.464343,"eighty":-0.316116,"marketCap":5175860},{"date":"2025-07-11","current":-0.507256,"twenty":-0.713373,"median":-0.4685,"eighty":-0.316507,"marketCap":5299493},{"date":"2025-07-18","current":-0.492044,"twenty":-0.712018,"median":-0.468907,"eighty":-0.317181,"marketCap":5140570},{"date":"2025-07-25","current":-0.481629,"twenty":-0.711655,"median":-0.470834,"eighty":-0.318566,"marketCap":5031760},{"date":"2025-08-01","current":-0.377197,"twenty":-0.710512,"median":-0.468907,"eighty":-0.319132,"marketCap":3940712},{"date":"2025-08-08","current":-0.389019,"twenty":-0.709863,"median":-0.4685,"eighty":-0.31949,"marketCap":4064227},{"date":"2025-08-15","current":-0.353066,"twenty":-0.70693,"median":-0.464343,"eighty":-0.320061,"marketCap":4296552},{"date":"2025-08-22","current":-0.351906,"twenty":-0.703381,"median":-0.462322,"eighty":-0.321248,"marketCap":4282436},{"date":"2025-08-29","current":-0.36249,"twenty":-0.700976,"median":-0.460599,"eighty":-0.322147,"marketCap":4411245},{"date":"2025-09-05","current":-0.368517,"twenty":-0.699677,"median":-0.459955,"eighty":-0.323573,"marketCap":4484589},{"date":"2025-09-12","current":-0.364907,"twenty":-0.698401,"median":-0.459424,"eighty":-0.324593,"marketCap":4440653},{"date":"2025-09-19","current":-0.386656,"twenty":-0.697939,"median":-0.457848,"eighty":-0.325298,"marketCap":4705328},{"date":"2025-09-26","current":-0.35814,"twenty":-0.697858,"median":-0.457139,"eighty":-0.326095,"marketCap":4358310},{"date":"2025-10-03","current":-0.353066,"twenty":-0.694336,"median":-0.454873,"eighty":-0.326416,"marketCap":4296552},{"date":"2025-10-10","current":-0.394389,"twenty":-0.691173,"median":-0.452245,"eighty":-0.32662,"marketCap":4799434},{"date":"2025-10-17","current":-0.654416,"twenty":-0.697858,"median":-0.454873,"eighty":-0.32682,"marketCap":7963767},{"date":"2025-10-24","current":-0.647649,"twenty":-0.698401,"median":-0.457139,"eighty":-0.327094,"marketCap":7881424},{"date":"2025-10-31","current":-0.566171,"twenty":-0.697939,"median":-0.457848,"eighty":-0.328539,"marketCap":6889891},{"date":"2025-11-07","current":-0.424876,"twenty":-0.697858,"median":-0.45875,"eighty":-0.329896,"marketCap":5170435},{"date":"2025-11-14","current":-0.817796,"twenty":-0.698401,"median":-0.459476,"eighty":-0.3307,"marketCap":11259057},{"date":"2025-11-21","current":-1.122489,"twenty":-0.704091,"median":-0.460563,"eighty":-0.331151,"marketCap":15453937},{"date":"2025-11-28","current":-1.325415,"twenty":-0.711053,"median":-0.461782,"eighty":-0.331323,"marketCap":18247728},{"date":"2025-12-05","current":-1.152349,"twenty":-0.717675,"median":-0.464302,"eighty":-0.331469,"marketCap":15865036},{"date":"2025-12-12","current":-0.692263,"twenty":-0.721216,"median":-0.467711,"eighty":-0.331585,"marketCap":9530767},{"date":"2025-12-19","current":-0.842172,"twenty":-0.721599,"median":-0.46888,"eighty":-0.33172,"marketCap":11594648},{"date":"2025-12-26","current":-0.847047,"twenty":-0.72928,"median":-0.468962,"eighty":-0.331777,"marketCap":11661766},{"date":"2026-01-02","current":-0.879344,"twenty":-0.733427,"median":-0.471638,"eighty":-0.331963,"marketCap":12106423},{"date":"2026-01-09","current":-0.801343,"twenty":-0.736748,"median":-0.472832,"eighty":-0.332335,"marketCap":11032534},{"date":"2026-01-16","current":-0.649606,"twenty":-0.736748,"median":-0.475311,"eighty":-0.333246,"marketCap":8943484},{"date":"2026-01-23","current":-0.588667,"twenty":-0.736748,"median":-0.476722,"eighty":-0.334203,"marketCap":8104508},{"date":"2026-01-30","current":-0.505791,"twenty":-0.736129,"median":-0.476844,"eighty":-0.335031,"marketCap":6963500},{"date":"2026-02-06","current":-0.47654,"twenty":-0.735261,"median":-0.476844,"eighty":-0.33585,"marketCap":6560792},{"date":"2026-02-09","current":-0.435102,"twenty":-0.735083,"median":-0.476783,"eighty":-0.336018,"marketCap":5990288}],"updateTime":1770731486502},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QNRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608926814","title":"Quoin Pharmaceuticals Files Initial Beneficial Ownership Statement for Stonepine Capital Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2608926814","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608926814?lang=en_us&edition=fundamental","pubTime":"2026-02-03 09:01","pubTimestamp":1770080483,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing identifies Stonepine Capital Management, LLC as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL20hFxM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Quoin Pharmaceuticals Files Initial Beneficial Ownership Statement for Stonepine Capital Management","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2606731248","title":"Quoin Pharmaceuticals Submits QRX003 for Orphan Drug Designation and Fast Track Review in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2606731248","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606731248?lang=en_us&edition=fundamental","pubTime":"2026-01-28 01:44","pubTimestamp":1769535858,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd. announced that it has submitted an application for Orphan Drug Designation  for its lead product candidate, QRX003, for the treatment of Netherton Syndrome to the Japanese Ministry of Health, Labour and Welfare . The MHLW has confirmed that QRX003 qualifies for both Orphan Drug Designation and Fast Track regulatory review status in Japan. QRX003 previously received Orphan Drug Designation from the U.S. Food and Drug Administration and the European Medicines Agency in 2025. If granted in Japan, QRX003 will have ODD status in Quoin's key commercial territories of the US, EU, and Japan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin Pharmaceuticals Ltd. published the original content used to generate this ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL9ZFPWQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","BK4585","BK4588","BK4139","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","QNRX","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014039.USD","BK4112","SG9999014021.USD","SG9999014005.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2606787367","title":"Quoin announces submission to Japanese MHLW for ODD for QRX003","url":"https://stock-news.laohu8.com/highlight/detail?id=2606787367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606787367?lang=en_us&edition=fundamental","pubTime":"2026-01-27 21:36","pubTimestamp":1769521010,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced that following a successful meeting with the Japanese MHLW that it has submitted an application for Orphan D...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-announces-submission-to-japanese-mhlw-for-odd-for-qrx003-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-announces-submission-to-japanese-mhlw-for-odd-for-qrx003-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4183","ODD","IE0009354923.USD","QNRX"],"gpt_icon":0},{"id":"2604115270","title":"Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application for QRX003 in Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2604115270","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604115270?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:30","pubTimestamp":1768915828,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd. has filed an application for Breakthrough Medicine Designation with the Saudi Food and Drug Authority  for QRX003, its lead investigational topical product for the treatment of Netherton Syndrome. If the designation is granted, QRX003 could become the first approved treatment for Netherton Syndrome and may be available for sale and reimbursement in Saudi Arabia in the second half of 2026. QRX003 is currently being evaluated in two late-stage clinical trials, with enrollment expected to be completed in the first half of 2026 and top-line data anticipated in the second half of the year. Quoin also plans to submit a New Drug Application in the United States and other territories pending successful clinical outcomes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be int","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL3CK6Kt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4585","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","BK4588","QNRX","LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014013.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014039.USD","BK4112","IE00BGHQF748.EUR","BK4139","SG9999014021.USD"],"gpt_icon":0},{"id":"2589781062","title":"ADRs Close Lower; Quoin Pharmaceuticals Ltd. Declines 36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589781062","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589781062?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:30","pubTimestamp":1764970200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed lower on Friday, as the S&P/BNY Mellon index of American depositary receipts declined 0.3% to 232.31.The European index dropped 0.5% to 204.74. The Asian index gained 0.4% to 310.61. The Latin American index fell 4.2% to 234.96, while the emerging-markets index was flat at 518.38.Quoin Pharmaceuticals Ltd., based in Israel, posted the largest decline, cratering 36% to $12.09, followed by shares of China's Adlai Nortye Ltd., which tumbled 16% to $1.01. Shares of China-based Akso Health Group tumbled 11% to $1.39.China's PomDoctor Ltd. was the biggest leader during the session, jumping 15% to $5.45, and Israel-based SaverOne 2014 Ltd. surged 13% to $1.07. Concord Medical Services Holdings Ltd., which is based in China, rounded out the top three leaders on Friday, with shares surging 13% to $3.99.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2589489208","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2589489208","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589489208?lang=en_us&edition=fundamental","pubTime":"2025-12-05 20:55","pubTimestamp":1764939318,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals  shares were 19% lower pre-bell Friday after a 6.1% increase in the previous session.Polyrizon  stock was down 17%, paring Thursday's rally.Domo  shares were 14% lower after the company reported late Thursday lower fiscal Q3 revenue.Parsons  stock was down 14% after a 1.9% gain in the previous session.Argan  shares were 11% lower, a day after the company posted lower fiscal Q3 revenue.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGX","LU0566484027.USD","QNRX","BK4023","BK4123","LU2065731478.USD","BK4139","BK4187","DOMO","PSN","BK4129","PLRZ","LU1559883803.SGD"],"gpt_icon":1},{"id":"2584670874","title":"Quoin Pharmaceuticals Approves New Stock Option Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2584670874","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584670874?lang=en_us&edition=fundamental","pubTime":"2025-11-18 06:34","pubTimestamp":1763418874,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals ( ($QNRX) ) has shared an update. On November 14, 2025, Quoin Pharmaceuticals‘ Board of Directors approved new award agreemen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-approves-new-stock-option-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-approves-new-stock-option-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2584167240","title":"Quoin Pharmaceuticals Unveils New Equity Incentive Plan for Executives and Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2584167240","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584167240?lang=en_us&edition=fundamental","pubTime":"2025-11-18 06:01","pubTimestamp":1763416895,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd. has approved new forms of stock option award agreements for directors and executive officers under its 2025 Equity Incentive Plan. The updated agreements allow options to be exercised through various payment methods, including cash, check, wire transfer, and cashless exercise mechanisms. In the event of termination, unvested awards will be forfeited immediately. Vested awards may be exercised for up to one year after death or disability, or up to three months after termination for reasons other than death, disability, or cause. All awards, whether vested or unvested, will be forfeited immediately upon termination for cause.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin Pharmaceuticals Ltd. published th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL8BpCPj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2582374169","title":"Quoin Pharmaceuticals Achieves Key Milestone in Rapamycin Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2582374169","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582374169?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:37","pubTimestamp":1762954664,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals ( ($QNRX) ) just unveiled an update. On November 11, 2025, Quoin Pharmaceuticals announced the successful achievement of targ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-achieves-key-milestone-in-rapamycin-delivery?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-achieves-key-milestone-in-rapamycin-delivery?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2582736485","title":"Quoin Pharmaceuticals Achieves Target Rapamycin Loadings in Topical Delivery Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2582736485","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582736485?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:31","pubTimestamp":1762867871,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd. has announced the successful achievement of target loading concentrations for its two proprietary topical rapamycin delivery technologies. The company has formulated a topical lotion with a 4% w/w rapamycin concentration and a dermal patch system with a 5% w/w concentration. These developments mark a significant milestone for Quoin's topical rapamycin programs. The company plans to begin manufacturing clinical trial and stability batches in the fourth quarter of 2025, with clinical testing set to commence in the first half of 2026. Initial clinical indications will include Microcystic Lymphatic Malformations and Venous Malformations, for which no FDA-approved treatments currently exist. The results have been announced by the company and clinical testing will be conducted in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL3QV5M2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2581144092","title":"Quoin Pharmaceuticals Ltd reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2581144092","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581144092?lang=en_us&edition=fundamental","pubTime":"2025-11-06 23:07","pubTimestamp":1762441625,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd reports results for the quarter ended September 30 - Earnings SummaryQuoin Pharmaceuticals Ltd QNRX.OQ reported a quarterly adjusted loss of $6.71 per share for the quarter e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL8N3WI2JB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2581929096","title":"Quoin Pharmaceuticals reports Q3 EPS ($6.71) vs. ($16.29) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2581929096","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581929096?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:36","pubTimestamp":1762436163,"startTime":"0","endTime":"0","summary":"“The third quarter of 2025 has been a period of significant momentum and strategic advancement for Quoin Pharmaceuticals (QNRX),” said Dr. Michael ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-reports-q3-eps-6-71-vs-16-29-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-reports-q3-eps-6-71-vs-16-29-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX"],"gpt_icon":0},{"id":"2581096917","title":"Quoin Pharmaceuticals sees cash runway into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096917?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:35","pubTimestamp":1762436138,"startTime":"0","endTime":"0","summary":"Quoin had approximately $5.4 million in cash, cash equivalents, and marketable securities as of September 30, 2025. The Company believes that this,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-sees-cash-runway-into-2027-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-sees-cash-runway-into-2027-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2581096317","title":"Quoin Pharmaceuticals Q3 EPS $(6.71) Misses $(6.50) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096317","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096317?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:34","pubTimestamp":1762436071,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(6.71) per share which missed the analyst consensus estimate of $(6.50) by 3.15 percent. This is a 59.21 percent increase over losses of $(16.45) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48684934/quoin-pharmaceuticals-q3-eps-6-71-misses-6-50-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"gpt_icon":0},{"id":"2581096365","title":"Press Release: Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096365","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096365?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:30","pubTimestamp":1762435800,"startTime":"0","endTime":"0","summary":"-- Private Placement Financing of Up to $105.3 Million Closed in October 2025 to Fund Operations and R&D. -- Sally Lawlor Appointed CFO to Support Commercialization and Financial Operations. -- Pediatric Netherton Clinical Program Expanded Based on Positive Long-Term Safety and Efficacy Data. -- QRX003 Pivotal Studies to Commence Enrollment in Q4 2025. Quoin continued to advance its lead clinical asset, QRX003, and recruitment into both pivotal trials for Netherton Syndrome will commence in Q4 this year. The Company also recently completed a private placement financing with the potential to raise up to $105.3 million in gross proceeds , received $3.3 million from the exercise of warrants issued in December 2024 and made the","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ETH.USD.HKCC","METHmain","QNRX"],"gpt_icon":0},{"id":"2580534447","title":"Quoin Pharmaceuticals Ltd  expected to post a loss of $4.98 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580534447","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580534447?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:51","pubTimestamp":1762267867,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd  expected to post a loss of $4.98 a share - Earnings Preview Quoin Pharmaceuticals Ltd QNRX.OQ, QNRX.O is expected to  show no change in quarterly revenue when it reports  re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL8N3WG256:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2579141614","title":"Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2579141614","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579141614?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:30","pubTimestamp":1761827400,"startTime":"0","endTime":"0","summary":"ASHBURN, Va., Oct.  30, 2025  (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \"Company\" or \"Quoin\"), a late clinical-stage specialty pharmaceutical company focused on rare and orpha","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/30/3177386/0/en/Quoin-Pharmaceuticals-to-Provide-Corporate-Update-and-Announce-Third-Quarter-2025-Financial-Results-on-Thursday-November-6-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2579186662","title":"Analysts Are Bullish on Top Healthcare Stocks: Quoin Pharmaceuticals (QNRX), Fulcrum Therapeutics (FULC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579186662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579186662?lang=en_us&edition=fundamental","pubTime":"2025-10-30 00:30","pubTimestamp":1761755411,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Quoin Pharmaceuticals (QNRX – Research Report) and F...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-quoin-pharmaceuticals-qnrx-fulcrum-therapeutics-fulc-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-quoin-pharmaceuticals-qnrx-fulcrum-therapeutics-fulc-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4139","BK4137","QNRX","XBI","BK4581","BK4585","LU0029874061.USD","HCSG","BK4007","LABU","BLSH","BK4112","LU0128526141.USD","FULC","BK4588"],"gpt_icon":0},{"id":"2578214952","title":"Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month ‘Whole Body’ Data Update from Ongoing Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2578214952","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578214952?lang=en_us&edition=fundamental","pubTime":"2025-10-28 20:30","pubTimestamp":1761654600,"startTime":"0","endTime":"0","summary":"Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study TargetCurrent Pediatric Patient in Ongoing Study Has Completely Healed Skin After 9 months of ‘Who","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175438/0/en/Quoin-Pharmaceuticals-Announces-Recruitment-of-Three-Additional-Patients-in-Investigator-Pediatric-Netherton-Syndrome-Study-and-Provides-Positive-9-month-Whole-Body-Data-Update-fro.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","IGA","BK4139"],"gpt_icon":0},{"id":"2578621443","title":"Quoin Pharmaceuticals’ QRX003 Lotion: A Promising Study for Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2578621443","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578621443?lang=en_us&edition=fundamental","pubTime":"2025-10-28 01:39","pubTimestamp":1761586747,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd (($QNRX)) announced an update on their ongoing clinical study. Quoin Pharmaceuticals Ltd is conducting a clinical study t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-qrx003-lotion-a-promising-study-for-netherton-syndrome?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-qrx003-lotion-a-promising-study-for-netherton-syndrome?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}]}}